GIPM
ATRC icon

G2 Investment Partners Management’s AtriCure ATRC Stock Holding History

G2 Investment Partners Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-29,691
Closed -$907K – 56
2024
Q4 		$907K Buy
29,691
+1,999
+7% +$64.3K 0.23% 59
2024
Q3 		$776K Buy
+27,692
New +$683K 0.22% 58

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

G2 Investment Partners Management's ATRC Position: Q1 2025 in Review

G2 Investment Partners Management sold out of AtriCure (ATRC) in Q1 2025, closing a stake of 29,691 shares — an estimated $907K sold.

G2 Investment Partners Management first reported a position in ATRC in Q3 2024 and held it in 2 quarters. The position peaked at $907K in Q4 2024. 221 funds tracked by Wall St. Rank hold ATRC as of Q1 2025.

  • G2 Investment Partners Management reported no remaining AtriCure position as of Q1 2025 after selling out during the quarter.
  • G2 Investment Partners Management sold 29,691 AtriCure shares in Q1 2025, an estimated $907K.
  • G2 Investment Partners Management first reported a position in AtriCure in Q3 2024 and held it in 2 quarters.
  • G2 Investment Partners Management's AtriCure position peaked at $907K in Q4 2024.
  • 221 funds tracked by Wall St. Rank held AtriCure as of Q1 2025.

Based on G2 Investment Partners Management's 13F filing for Q1 2025, filed 15 May 2025.